Episode 042: Myeloma Series, Pt.3 - Intro to ...

This week we kick off a brand-new series on pancreatic cancer, starting with the fundamentals. Using the case of a 68-year-old man with painless jaundice, weight loss, and new-onset diabetes, we cover the epidemiology and sobering survival statistics of pancreatic ductal adenocar ...  Show more

This week we wrap up our two-part CLL update by turning to relapsed and refractory disease. We pick up with the 68-year-old man from Part 1, now a year out from frontline therapy and showing signs of relapse. We cover when relapse actually needs treatment, the history of BTK inhi ...  Show more

This week’s episode is part 2 of our plasma cell dyscrasias series. We will go over the important details on risk stratification, as well as initial and relapse treatment options for Multiple Myeloma, with key details on the pharmacology of myeloma drugs.

In this episode I cover myeloma.

If you want to follow along with written notes on myeloma go to zerotofinals.com/medicine/haematology/myeloma/ or the haematology section in the Zero to Finals medici ...

This episode is a continuation of the Hematology and Oncology chapter of Crush Step 1. Content covered includes: - Lymphomas - Histiocyte Disorders (Langerhans Cell Histiocytosis [LCH] and Histiocytosis X) - Plasma Cell Disorders (Multiple Myeloma, Waldenström Macroglobulinemia [ ...  Show more

Joseph Mikhael, MD, and Irene Ghobrial, MD, discuss screening high-risk populations for early-stage multiple myeloma and new techniques to detect it. Relevant disclosures can be found with the episode show notes on Medscape.com ( https://www.medscape.com/viewarticle/964336). The t ...  Show more